A report has revealed that three Ebola-infected doctors who were given doses of the experimental drug last Thursday have shown remarkable signs of improvement.
The drug, ZMapp was earlier given to two United States (U.S.) Aid workers infected with the disease who were flown home for treatment.
The disease although does not have a cure as yet but the World Health Organization (WHO) has approved the use of untested drugs considering the magnitude of outbreak in West Africa, reported the BBC.
The disease has claimed the lives of 1,229 people since the beginning of the year.
Ebola is transmitted by direct contact with the body fluids of an infected person. The epidemic began in Guinea and spread to Liberia, Sierra Leone and Nigeria.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app